prof. dr. K. (Klaas) Poelstra



Postal address:
A Deusinglaan1
Gebouw 5161, ruimte 0509
9713 AV
Phone: +31 50 363 7721Fax: +31 50 363 3247
  1. 2020
  2. 2019
  3. 2018
  4. Deshmukh, M., Nakagawa, S., Higashi, T., Vincek, A., Venkatesh, A., Ruiz de Galarreta, M., ... Hoshida, Y. (2018). Cell type-specific pharmacological kinase inhibition for cancer chemoprevention. Nanomedicine-Nanotechnology biology and medicine, 14(2), 317-325.
  5. Broesder, A., Teekamp, N., van Dijk, F., Beljaars, E., Hinrichs, W., Poelstra, K., ... Olinga, P. (2018). Formulation of biodegradable microspheres for the sustained release of PDGFβ-receptor directed HSA targeted to fibrotic tissue. Poster session presented at 11th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Granada, Spain.
  6. 2017
  7. Magdaleno, F., Klein, S., Frohn, F., Reker-Smit, C., Uschner, F. E., Schierwagen, R., ... Trebicka, J. (2017). Rho-kinase inhibitor coupled with peptide-modified albumin carrier reduces fibrogenesis and portal pressure in cirrhotic rats without systemic effects. Hepatology, 66(1 (Suppl.)), 142A-142A.
  8. 2016
  9. Teekamp, N., van Dijk, F., Beljaars, E., Post, E., Hinrichs, W., Poelstra, K., & Olinga, P. (2016). Biodegradable microspheres for the sustained release of ppB-HSA to target PDGFβ-receptors in fibrotic tissues. Poster session presented at 14th European Symposium on Controlled Drug Delivery (ESCDD), Egmond aan Zee, Netherlands.
  10. 2015
  11. Poelstra, K. (2015). Meet the UMCG, section Drug Targeting. Abstract from Medical Sciences Spring School: Vascular Medicine about Mechanisms of vascular disease in diabetes mellitus - Perspectives for Health Ageing, Groningen, Netherlands.
  12. 2014
  13. 2013
  14. Poelstra, K., Prakash, J., Beljaars, E., & Bansal, R. (2013). IPC No. A61K38/21. Interferon Analogs. Manuscript submitted for publication. (Patent No. US2013064791A1).
  15. 2012
  16. Rachmawati, H., Mattos Pinto, A., Reker-Smit, C., Poelstra, K., & Beljaars, L. (2012). Modification of Interleukin-10 with Mannose-6-Phosphate Groups Yields a Liver-Specific Cytokine with Antifibrotic Activity in Rats. In Pharmacology, Toxicology and Pharmaceutical Science: Pharmacology (pp. 161-176). [DOI: 10.5772/33440] InTech.
  17. 2011
Previous 1 2 3 4 Next

ID: 128486